Skip to main content
. 2024 Mar 1;13:26. doi: 10.1186/s40164-024-00493-8

Table 3.

Common ADC payloads

Type of toxic payload Payload Representative tumor-targeting ADCs
Microtubule-targeting payload Maytansinoids PF-06647020
Auristatin IMGN901, MRG003, Teliso-V, BA3011 TIVDAK, Glembatumumab vedotin, Tisotumab vedotin, EnaV
Eribulin BB-1701
Tubulysins EC1428
Cryptophycins Dictyostatin
EG5 inhibitors
DNA-targeting payload Enediyne Loncastuximab tesirine-lpyl
Topoisomerase I inhibitors DXd
PBD Zynlonta
Duocarmycins Trastuzumab duocarmazine
RNA-targeting payload Thailanstatin MC-Thailanstatin A
Amatoxins
Immune agonist Toll-like receptor agonists BDC-1001, Silverback
STING agonists XMT-2056
Glucocorticoid receptor modulators ABBV-319

ADC antibody drug conjugate, PBD pyrrolobenzodiazepines